Disodium hydrogen phosphate dihydrate
Synonym(s):Disodium phosphate;Sodium phosphate dibasic dihydrate;Disodium hydrogen phosphate dihydrate;di-Sodium hydrogen phosphate dihydrate;sec-Sodium phosphate
- CAS NO.:10028-24-7
- Empirical Formula: 2Na.HO4P.2H2O
- Molecular Weight: 177.99
- MDL number: MFCD00149182
- EINECS: 600-053-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-10-30 18:52:02
What is Disodium hydrogen phosphate dihydrate?
Chemical properties
solid
Chemical properties
The USP 32 states that dibasic sodium phosphate is dried or
contains, 1, 2, 7, or 12 molecules of water of hydration.
Anhydrous dibasic sodium phosphate occurs as a white powder.
The dihydrate occurs as white or almost white, odorless crystals.
The heptahydrate occurs as colorless crystals or as a white granular
or caked salt that effloresces in warm, dry air. The dodecahydrate
occurs as strongly efflorescent, colorless or transparent crystals.
The Uses of Disodium hydrogen phosphate dihydrate
Laxative.
The Uses of Disodium hydrogen phosphate dihydrate
Sodium Phosphate Dibasic Dihydrate is a treatment of Ischemic stroke with aptamers targeting toll-like receptor 4 (TLR-4).
The Uses of Disodium hydrogen phosphate dihydrate
Sodium phosphate dibasic dihydrate has been used for isolating DNA and RNA from bacterial samples of human gastrointestinal (GI) tract.
What are the applications of Application
Sodium phosphate dibasic dihydrate is a reagent with high buffering capacity
Definition
ChEBI: A hydrate that is the dihydrate form of disodium hydrogenphosphate
Production Methods
Either bone phosphate (bone ash), obtained by heating bones to
whiteness, or the mineral phosphorite is used as a source of tribasic
calcium phosphate, which is the starting material in the industrial
production of dibasic sodium phosphate.
Tribasic calcium phosphate is finely ground and digested with
sulfuric acid. This mixture is then leached with hot water and
neutralized with sodium carbonate, and dibasic sodium phosphate
is crystallized from the filtrate.
Pharmaceutical Applications
Dibasic sodium phosphate is used in a wide variety of pharmaceutical
formulations as a buffering agent and as a sequestering agent.
Therapeutically, dibasic sodium phosphate is used as a mild laxative
and in the treatment of hypophosphatemia.
Dibasic sodium phosphate is also used in food products; for
example as an emulsifier in processed cheese.
Biochem/physiol Actions
Sodium phosphate dibasic dehydrate is an important component of running buffer of denaturing gel electrophoresis.
Safety
Dibasic sodium phosphate is widely used as an excipient in
parenteral, oral, and topical pharmaceutical formulations.
Phosphate occurs extensively in the body and is involved in
many physiological processes since it is the principal anion of
intracellular fluid. Most foods contain adequate amounts of
phosphate, making hypophosphatemia (phosphate deficiency)
virtually unknown except for certain disease states or in patients
receiving total parenteral nutrition. Treatment is usually by the oral
administration of up to 100 mmol of phosphate daily.
Approximately two-thirds of ingested phosphate is absorbed
from the gastrointestinal tract, virtually all of it being excreted in the
urine, and the remainder is excreted in the feces.
Excessive administration of phosphate, particularly intravenously,
rectally, or in patients with renal failure, can cause
hyperphosphatemia that may lead to hypocalcemia or other severe
electrolyte imbalances. Adverse effects occur less frequently
following oral consumption, although phosphates act as mild saline
laxatives when administered orally or rectally. Consequently,
gastrointestinal disturbances including diarrhea, nausea, and
vomiting may occur following the use of dibasic sodium phosphate
as an excipient in oral formulations. However, the level of dibasic
sodium phosphate used as an excipient in a pharmaceutical
formulation is not usually associated with adverse effects.
LD50 (rat, oral): 17 g/kg
storage
The anhydrous form of dibasic sodium phosphate is hygroscopic.
When heated to 40℃, the dodecahydrate fuses; at 100℃ it loses its
water of crystallization; and at a dull-red heat (about 240℃) it is
converted into the pyrophosphate, Na4P2O7. Aqueous solutions of
dibasic sodium phosphate are stable and may be sterilized by
autoclaving.
The bulk material should be stored in an airtight container, in a
cool, dry place.
Incompatibilities
Dibasic sodium phosphate is incompatible with alkaloids, antipyrine, chloral hydrate, lead acetate, pyrogallol, resorcinol and calcium gluconate, and ciprofloxacin. Interaction between calcium and phosphate, leading to the formation of insoluble calcium-phosphate precipitates, is possible in parenteral admixtures.
Regulatory Status
GRAS listed. Accepted in Europe for use as a food additive. Included in the FDA Inactive Ingredients Database (injections; infusions; nasal, ophthalmic, oral, otic, topical, and vaginal preparations). Included in nonparenteral and parenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.
Properties of Disodium hydrogen phosphate dihydrate
Melting point: | 92,5°C |
Density | 1.064 g/mL at 20 °C |
vapor density | 4.9 (vs air) |
storage temp. | Store at +5°C to +30°C. |
solubility | H2O: 0.5 M at 20 °C, clear, colorless |
form | powder |
color | White |
Odor | Odorless |
PH | 8.9-9.2 (25℃, 0.5M in H2O) |
PH Range | 9.1 |
Water Solubility | Soluble in water |
λmax | λ: 260 nm Amax: 0.03 λ: 280 nm Amax: 0.03 |
Stability: | Stable. Incompatible with strong oxidizing agents. |
CAS DataBase Reference | 10028-24-7(CAS DataBase Reference) |
EPA Substance Registry System | Disodium phosphate dihydrate (10028-24-7) |
Safety information for Disodium hydrogen phosphate dihydrate
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for Disodium hydrogen phosphate dihydrate
InChIKey | KDQPSPMLNJTZAL-UHFFFAOYSA-L |
Abamectin manufacturer
Kronox Lab Sciences Pvt Ltd
Annexe Chem Pvt Ltd
VM Chemicals
Pd Navkar Bio Chem Pvt Ltd
Skc Chemie Pvt Ltd
Nandu Chemical Industries
Imperial Chem Incorporation (part of Imperial Group)
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
Phosphoric acid disodium salt dihydrate 98%View Details
-
Sodium Phosphate Dibasic Dihydrate for HPLC CAS 10028-24-7View Details
10028-24-7 -
Di-Sodium Hydrogen ortho phosphate Anhydrous (ER) CAS 10028-24-7View Details
10028-24-7 -
Di-Sodium Hydrogen Orthophosphate CAS 10028-24-7View Details
10028-24-7 -
Sodium Phosphate Dibasic Dihydrate extrapure AR CAS 10028-24-7View Details
10028-24-7 -
Sodium Phosphate Dibasic Dihydrate for molecular biology CAS 10028-24-7View Details
10028-24-7 -
Di Sodium Hydrogen orthophosphate CAS 10028-24-7View Details
10028-24-7 -
Di Sodium Hydrogen Phosphate Dihydrate LR 98% CAS 10028-24-7View Details
10028-24-7